Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Melanoma 2 Vaping 1 Uterine Cervical Dysplasia 1 Smoking Cessation 1 Pain 1 Nevus, Spindle Cell 1 Nevus, Pigmented 1 Nevus, Epithelioid and Spindle Cell 1 Nevus, Blue 1 Nevus 1 Nevi and Melanomas 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Dysplastic Nevus Syndrome 1 Cutaneous Squamous Cell Carcinoma 1 Breast Neoplasms 1 Agnosia 1

Interventions

Peripheral Blood Stem Cell Transplantation 39 fludarabine phosphate 37 Cyclophosphamide 33 Mycophenolic Acid 28 Whole-Body Irradiation 24 Cyclosporine 24 Tacrolimus 22 Radiotherapy 19 Methotrexate 18 Busulfan 18 Antilymphocyte Serum 17 Flow Cytometry 14 Filgrastim 14 Etoposide 14 Vorinostat 11 Bortezomib 11 Bexarotene 11 mogamulizumab 10 Methylprednisolone 10 Lenalidomide 10 pembrolizumab 9 Rituximab 9 Melphalan 9 Gemcitabine 9 Brentuximab Vedotin 9 romidepsin 8 Therapeutics 8 Psychiatric Rehabilitation 8 Polymerase Chain Reaction 8 Methoxsalen 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mycosis Fungoides × Transdermal Patch × Clear all

NCT02192021 2024-08-09

MNA-D

University of Pittsburgh

Phase 1 Completed

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡